Connection
Elaine Morrato to Retrospective Studies
This is a "connection" page, showing publications Elaine Morrato has written about Retrospective Studies.
|
|
Connection Strength |
|
 |
|
 |
|
0.330 |
|
|
|
-
McManus BM, Richardson Z, Schenkman M, Murphy NJ, Everhart RM, Hambidge S, Morrato E. Child characteristics and early intervention referral and receipt of services: a retrospective cohort study. BMC Pediatr. 2020 02 22; 20(1):84.
Score: 0.049
-
Morrato EH, Campagna EJ, Brewer SE, Dickinson LM, Thomas DS, Miller BF, Dearing J, Druss BG, Lindrooth RC. Metabolic Testing for Adults in a State Medicaid Program Receiving Antipsychotics: Remaining Barriers to Achieving Population Health Prevention Goals. JAMA Psychiatry. 2016 Jul 01; 73(7):721-30.
Score: 0.038
-
Morrato EH, Parks J, Campagna EJ, Muser E, Thomas DS, Fang H, Doshi D. Comparative effectiveness of injectable paliperidone palmitate versus oral atypical antipsychotics: early postmarketing evidence. J Comp Eff Res. 2015 Mar; 4(2):89-99.
Score: 0.034
-
Root ED, Thomas DS, Campagna EJ, Morrato EH. Adjusting for geographic variation in observational comparative effectiveness studies: a case study of antipsychotics using state Medicaid data. BMC Health Serv Res. 2014 Aug 27; 14:355.
Score: 0.034
-
Victoroff MS, Drury BM, Campagna EJ, Morrato EH. Impact of electronic health records on malpractice claims in a sample of physician offices in Colorado: a retrospective cohort study. J Gen Intern Med. 2013 May; 28(5):637-44.
Score: 0.030
-
Morrato EH, Druss BG, Hartung DM, Valuck RJ, Thomas D, Allen R, Campagna E, Newcomer JW. Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users. Pharmacoepidemiol Drug Saf. 2011 Jan; 20(1):66-75.
Score: 0.026
-
Morrato EH, Nicol GE, Maahs D, Druss BG, Hartung DM, Valuck RJ, Campagna E, Newcomer JW. Metabolic screening in children receiving antipsychotic drug treatment. Arch Pediatr Adolesc Med. 2010 Apr; 164(4):344-51.
Score: 0.025
-
Morrato EH, Cuffel B, Newcomer JW, Lombardo I, Kamat S, Barron J. Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients. J Clin Psychopharmacol. 2009 Feb; 29(1):26-32.
Score: 0.023
-
Morrato EH, Newcomer JW, Allen RR, Valuck RJ. Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data. J Clin Psychiatry. 2008 Feb; 69(2):316-22.
Score: 0.021
-
Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R, Valuck RJ. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003. Clin Ther. 2007 Jan; 29(1):183-95.
Score: 0.020
-
S?mme S, Bronsert M, Morrato E, Ziegler M. Frequency and variety of inpatient pediatric surgical procedures in the United States. Pediatrics. 2013 Dec; 132(6):e1466-72.
Score: 0.008
-
Erickson MA, Morrato EH, Campagna EJ, Elise B, Miller NH, Kempe A. Variability in spinal surgery outcomes among children's hospitals in the United States. J Pediatr Orthop. 2013 Jan; 33(1):80-90.
Score: 0.007
-
Banta JE, Morrato EH, Lee SW, Haviland MG. Retrospective analysis of diabetes care in California Medicaid patients with mental illness. J Gen Intern Med. 2009 Jul; 24(7):802-8.
Score: 0.006
-
Valuck RJ, Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R. How expensive is antipsychotic polypharmacy? Experience from five US state Medicaid programs. Curr Med Res Opin. 2007 Oct; 23(10):2567-76.
Score: 0.005
-
McCollum M, Ellis SL, Morrato EH, Sullivan PW. Prevalence of multiple cardiac risk factors in US adults with diabetes. Curr Med Res Opin. 2006 Jun; 22(6):1031-4.
Score: 0.005
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|